Increased fat mass is an established risk factor for the cardiometabolic diseases type 2 diabetes and cardiovascular disease (CVD) and is associated with increased risk of all-cause and CVD mortality. However, also very low fat mass associates with such an increased risk. Whether impaired metabolic health, characterized by hypertension, dyslipidemia, hyperglycemia, insulin resistance, and subclinical inflammation, may explain part of the elevated risk of cardiometabolic diseases that is found in many subjects with very low fat mass, as it does in many obese subjects, is unknown. An important pathomechanism of impaired metabolic health is disproportionate fat distribution. In this article the risk of cardiometabolic diseases and mortality in subjects with metabolically healthy and unhealthy normal weight and obesity is summarized. Furthermore, the change of metabolic health during a longer period of follow-up and its impact on cardiometabolic diseases is being discussed. Finally, the implementation of the concept of metabolic health in daily clinical practice is being highlighted.
Citations
Citations to this article as recorded by
Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight Rachel Agius, Nikolai P. Pace, Stephen Fava Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef
Comparing verum and sham acupoint catgut embedding for adults with obesity: A systematic review and meta-analysis of randomized clinical trials Jin-huan Yue, Xiao-ling Li, Yu-ying Zhang, Guan-hu Yang, Jeffrey Zhong-xue Mah, Ang Li, Wei-wei Zhao, Yu-lin Wang, Qin-hong Zhang, Jia-qi Huang Medicine.2024; 103(4): e36653. CrossRef
Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers Joon-Young Yoon, Won Ju Park, Hee Kyung Kim, Ho-Cheol Kang, Cheol-Kyu Park, Wonsuk Choi Journal of Obesity & Metabolic Syndrome.2024; 33(1): 36. CrossRef
Dietary intake of methyl donor nutrients in relation to metabolic health status, serum levels of brain-derived neurotrophic factor and adropin Donya Poursalehi, Keyhan Lotfi, Farnaz Shahdadian, Zahra Hajhashemy, Parisa Rouhani, Parvane Saneei Clinical Nutrition.2024; 43(6): 1353. CrossRef
Metabolically Healthy Obesity: An Eye-opener Purushothaman Padmanabhan, Nagendram Dinakaran, Somnath Verma, S Keerthana Gastroenterology, Hepatology and Endoscopy Practice.2023; 3(1): 1. CrossRef
Effect of metabolic health and obesity on all-cause death and CVD incidence in Korean adults: a retrospective cohort study Ye-Seul Kim, Sang-Jun Shin, Yonghwan Kim, Joungyoun Kim, Hee-Taik Kang Scientific Reports.2023;[Epub] CrossRef
Coffee and metabolic phenotypes: A cross-sectional analysis of the Japan multi-institutional collaborative cohort (J-MICC) study Takeshi Watanabe, Kokichi Arisawa, Tien Van Nguyen, Masashi Ishizu, Sakurako Katsuura-Kamano, Asahi Hishida, Takashi Tamura, Yasufumi Kato, Rieko Okada, Rie Ibusuki, Chihaya Koriyama, Sadao Suzuki, Takahiro Otani, Teruhide Koyama, Satomi Tomida, Kiyonori Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(3): 620. CrossRef
Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity? Myong-Won Seo, Joon Young Kim Obesity Research & Clinical Practice.2023; 17(2): 116. CrossRef
Association between metabolic obesity phenotypes and multiple myeloma hospitalization burden: A national retrospective study Yue Zhang, Xiude Fan, Chunhui Zhao, Zinuo Yuan, Yiping Cheng, Yafei Wu, Junming Han, Zhongshang Yuan, Yuanfei Zhao, Keke Lu Frontiers in Oncology.2023;[Epub] CrossRef
Metabolically healthy obesity: Misleading phrase or healthy phenotype? Cem Tanriover, Sidar Copur, Abduzhappar Gaipov, Batu Ozlusen, Rustu E. Akcan, Masanari Kuwabara, Mads Hornum, Daniel H. Van Raalte, Mehmet Kanbay European Journal of Internal Medicine.2023; 111: 5. CrossRef
Prevalence of combined metabolic health and weight status by various diagnosis criteria and association with cardiometabolic disease in Korean adults Myong-Won Seo, Jung-Min Lee, Hyun Chul Jung Obesity Research & Clinical Practice.2023; 17(2): 137. CrossRef
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification Åsa Johansson, Ole A. Andreassen, Søren Brunak, Paul W. Franks, Harald Hedman, Ruth J. F. Loos, Benjamin Meder, Erik Melén, Craig E. Wheelock, Bo Jacobsson Journal of Internal Medicine.2023; 294(4): 378. CrossRef
Lipid droplet biogenesis and functions in health and disease Armella Zadoorian, Ximing Du, Hongyuan Yang Nature Reviews Endocrinology.2023; 19(8): 443. CrossRef
Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity Dariusz Szukiewicz International Journal of Molecular Sciences.2023; 24(12): 9818. CrossRef
Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery Sophia M. Schmitz, Sebastian Storms, Alexander Koch, Christine Stier, Andreas Kroh, Karl P. Rheinwalt, Sandra Schipper, Karim Hamesch, Tom F. Ulmer, Ulf P. Neumann, Patrick H. Alizai Biomedicines.2023; 11(6): 1595. CrossRef
Hyperleptinemia as a marker of various phenotypes of obesity and overweight in women with rheumatoid arthritis and systemic lupus erythematosus L. V. Kondrateva, Yu. N. Gorbunova, T. A. Panafidina, T. V. Popkova Rheumatology Science and Practice.2023; 61(3): 339. CrossRef
Predictable Representation of Metabolic Synthesis Pathways of Vitamins and Short-Chain Fatty Acids in Obese Adults A. V. Shestopalov, L. A. Ganenko, I. M. Kolesnikova, T. V. Grigoryeva, I. Yu. Vasilyev, Yu. L. Naboka, N. I. Volkova, O. V. Borisenko, S. A. Roumiantsev Journal of Evolutionary Biochemistry and Physiology.2023; 59(5): 1510. CrossRef
PREDICTION OF VITAMINS AND SHORT-CHAIN FATTY ACIDS SYNTHESIS PATHWAYS IN OBESE ADULTS A. V. Shestopalov, L. A. Ganenko, I. M. Kolesnikova, T. V. Grigoryeva, I. Yu. Vasilyev, Yu. L. Naboka, N. I. Volkova, O. V Borisenko, S. A. Roumiantsev Журнал эволюционной биохимии и физиологии.2023; 59(5): 389. CrossRef
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity Nam Hoon Kim, Kyeong Jin Kim, Jimi Choi, Sin Gon Kim Metabolism.2022; 128: 154894. CrossRef
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women Boyoung Park Journal of Gynecologic Oncology.2022;[Epub] CrossRef
Insulin and cancer: a tangled web Brooks P. Leitner, Stephan Siebel, Ngozi D. Akingbesote, Xinyi Zhang, Rachel J. Perry Biochemical Journal.2022; 479(5): 583. CrossRef
Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study Shao-Chi Chu, Po-Hsi Wang, Kuan-Ying Lu, Chia-Chun Ko, Yun-Hsuan She, Chin-Chan Lee, I-Wen Wu, Chiao-Yin Sun, Heng-Jung Hsu, Heng-Chih Pan Frontiers in Public Health.2022;[Epub] CrossRef
Dissecting the clinical relevance of polygenic risk score for obesity—a cross-sectional, longitudinal analysis Eun Kyung Choe, Manu Shivakumar, Seung Mi Lee, Anurag Verma, Dokyoon Kim International Journal of Obesity.2022; 46(9): 1686. CrossRef
Metabolic and Obesity Phenotype Trajectories in Taiwanese Medical Personnel Hsin-Yun Chang, Jer-Hao Chang, Yin-Fan Chang, Chih-Hsing Wu, Yi-Ching Yang International Journal of Environmental Research and Public Health.2022; 19(13): 8184. CrossRef
Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose Inflammation Haneen S. Dwaib, Ibrahim AlZaim, Ghina Ajouz, Ali H. Eid, Ahmed El-Yazbi Molecular Pharmacology.2022; 102(1): 60. CrossRef
Reduced leukocyte mitochondrial copy number in metabolic syndrome and metabolically healthy obesity Rachel Agius, Nikolai Paul Pace, Stephen Fava Frontiers in Endocrinology.2022;[Epub] CrossRef
Changes in BMI and physical activity from youth to adulthood distinguish normal-weight, metabolically obese adults from those who remain healthy A. Viitasalo, K. Pahkala, T. Lehtimäki, JSA. Viikari, TH. Tammelin, O. Raitakari, TO. Kilpeläinen Frontiers in Endocrinology.2022;[Epub] CrossRef
Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity Yun Kyung Cho, Yoo La Lee, Chang Hee Jung International Journal of Molecular Sciences.2022; 23(17): 9614. CrossRef
Metabolically healthy obesity: it is time to consider its dynamic changes Yun Kyung Cho, Chang Hee Jung Cardiovascular Prevention and Pharmacotherapy.2022; 4(4): 123. CrossRef
Obesity as a Risk Factor for Breast Cancer—The Role of miRNA Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, Katarzyna Urbańska, Filip Ambrozkiewicz, Andrzej Kwiatkowski, Lidia Martyńska, Anita Domańska, Wojciech Bik, Agnieszka Paziewska International Journal of Molecular Sciences.2022; 23(24): 15683. CrossRef
Propensity Score–Matching Sleeve Gastrectomy (SG) vs. Gastric Bypass (RYGB) in Patients ≥ 60 Years Omar Thaher, Stefanie Wolf, Martin Hukauf, Christine Stroh Obesity Surgery.2021; 31(6): 2682. CrossRef
Associations between obesity, metabolic health, and the risk of breast cancer in East Asian women Boyoung Park, Soyeoun Kim, Hayoung Kim, Chihwan Cha, Min Sung Chung British Journal of Cancer.2021; 125(12): 1718. CrossRef
Seung Hwan Lee, Hee Sung Ha, Young Jun Park, Jin Hee Lee, Hyeon Woo Yim, Kun Ho Yoon, Moo Il Kang, Won Chul Lee, Ho Young Son, Yong Moon Park, Hyuk Sang Kwon
Endocrinol Metab. 2011;26(2):133-141. Published online June 1, 2011
BACKGROUND We attempted to determine the prevalence and characteristics of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) individuals in a large cohort of middle-aged Koreans. METHODS: 8,987 non-diabetic subjects were selected from the Chungju Metabolic disease Cohort Study performed in 2003-2006. MONW was defined as a body mass index (BMI) > or = 18.5 and < 23 kg/m2 with a homeostasis model assessment of insulin resistance (HOMA-IR) in the highest quartile. MHO was defined as BMI > or = 25 kg/m2 with HOMA-IR in the lowest quartile. RESULTS: The mean age of the subjects was 62.3 +/- 10.5 years (men 40.4%). The age-adjusted prevalence of MONW and MHO were 4.3% (5.3% men, 3.7% women) and 5.6% (3.6% men, 7.0% women), respectively. 14.2% of men and 12.9% of women were classified as MONW among the normal weight population, whereas 10.7% of men and 14.5% of women were classified as MHO among the obese subjects. The prevalence of prediabetes was significantly higher in the MONW group than in the MHO group (34.7 vs. 12.5%, P < 0.0001 in men; 23.1 vs. 8.8%, P < 0.0001 in women). The MONW group evidenced an equivalent risk of coronary heart disease (CHD) relative to the MHO group (10.77 +/- 0.68 vs. 10.22 +/- 0.90% in men; 7.02 +/- 0.34 vs. 7.26 +/- 0.26% in women, means +/- standard error [SE]). CONCLUSION: The subjects in the MONW group are characterized by a high risk of diabetes and CHD, despite their normal weights. Their substantial prevalence in the population emphasizes the importance of identifying subjects in the MONW group, and warrants more intensive risk management.
Citations
Citations to this article as recorded by
Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea Hae Kyung Yang, Kyungdo Han, Hyuk-Sang Kwon, Yong-Moon Park, Jae-Hyoung Cho, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Seung-Hwan Lee Scientific Reports.2016;[Epub] CrossRef
The Definition of Metabolically Healthy Obesity Hae Kyung Yang, Seung-Hwan Lee The Journal of Korean Diabetes.2014; 15(1): 17. CrossRef